Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Would it have been better for TPL to have the patents re-emamed first?

And how goofy would THAT have looked? "We have so little confidence in our patents that we, the patent owners, request redundant validation by the USPTO".

And now ask yourself: if WE requested the re-exam, would it have been handled "ex parte"? If so, what would have been the point? If not, why would we want to open it up to everyone and his brother?

JMHOs,

SGE

Share
New Message
Please login to post a reply